Status
Conditions
Treatments
About
This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activity trackers), dietary habits and self-assessed health will be compared between patients that receive only the activity tracker and written information (group A), receive the activity tracker, written information and a personalized physical activity prescription (group B), and those that receive in addition also intensive follow-up with motivational interview by physician assistants and a dietitian (group C)
Full description
This is a three-arm clinical trial studying the effect of providing activity trackers with intensive motivational interview by trained physician assistants, and dietitian counselling, on the levels of daily physical activity among Arabic- speaking residents of East Jerusalem with prediabetes from Clalit Health Services. In addition, this study will also assess healthy dietary changes, and self assessed health and quality of life.
The study will compare three groups (total 375, each group 125):
Group A - will receive activity trackers and written educational handouts in addition to their usual care.
Group B - will receive all of group A intervention components and also a personalized physical activity prescription.
Group C - will receive all of group B components and also intensive motivational interview support by trained physician assistants (3 sessions), and dietitian support (two sessions).
Each participant will be followed-up for six months, with data collection occurring at baseline, three months and six months. Data collection will include average weekly steps, blood pressure, anthropometric measurements, routine blood tests (including fasting glucose, HbA1C, and lipid profile), physical activity survey, Mediterranean dietary habits survey, Food Frequency Questionnaire, and quality of life survey.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.
Exclusion criteria
Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%
Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications
Artificial lower limbs or inability to walk normally (eg: stroke with plegia)
Chronic obstructive pulmonary disease
Known heart disease (with impaired exercise tolerance)
Pregnancy
Medical conditions:
Primary purpose
Allocation
Interventional model
Masking
375 participants in 3 patient groups
Loading...
Central trial contact
Amnon Lahad, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal